Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.news-medical.net/news/20230124/New-study-evaluates-the-safety-profile-of-the-BNT162b2-vaccine-in-New-Zealand.aspx
0
0
New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand - News-Medical.Net
1/24/23 at 4:28pm
Organization
News-Medical.Net
45 words
0
Comments
Researchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.
Public Health
Public Safety
Infectious Diseases
Medical Procedures
AESIs
BNT162b2
New Zealand
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...